[1]
E. Sbidian, “Choice of Systemic Drugs for the Management of Moderate-to-severe Psoriasis: A Cross-country Comparison Based on National Health Insurance Data”, Acta Derm Venereol, vol. 101, no. 6, p. adv00473, Jun. 2021.